Maze Therapeutics (MAZE) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Maze Therapeutics Revenue Highlights


00

Maze Therapeutics Revenue by Period


Maze Therapeutics Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$167.50M100.00%
2023-12-31-100.00%
2022-12-31--

Maze Therapeutics generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Maze Therapeutics Revenue by Quarter

DateRevenueChange
2026-06-30--100.00%
2026-03-31$20.00M100.00%
2025-12-31-100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31--100.00%
2024-09-30$2.50M-98.48%
2024-06-30$165.00M100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30--

Maze Therapeutics generated - in revenue during Q2 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Maze Therapeutics Revenue Breakdown


Maze Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 26
UNITED STATES$20.00M

Maze Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (100.00%).

Maze Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$874.84M$218.25M
ARDXArdelyx$407.32M$120.88M
WVEWave Life Sciences$42.73M$2.27M
IMNMImmunome$6.94M-
NTLAIntellia Therapeutics-$7.66M
SIONSionna Therapeutics--
PHVSPharvaris--
SYRESpyre Therapeutics--
TRVITrevi Therapeutics--
MAZEMaze Therapeutics--
ZYMEZymeworks$-27.11M-

MAZE Revenue FAQ


What is Maze Therapeutics’s yearly revenue?

Maze Therapeutics's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $167.5M, representing an increase of 100.00% compared to 2023. MAZE's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Maze Therapeutics’s quarterly revenue?

Maze Therapeutics's quarterly revenue for Q2 2026 was $0, a -100.00% decrease from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $20M, a 100.00% increase from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). MAZE's quarterly revenue for Q4 2025 was $0, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Maze Therapeutics’s revenue growth rate?

Maze Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%